Celularity Inc. received a notice from Nasdaq for not filing its Quarterly Report on Form 10-Q for the period ended June 30, 2025, putting it in non-compliance with Listing Rule 5250 (c)(1). Nasdaq has granted the company until August 31, 2025, to file the report. Celularity has until September 5, 2025, to submit an update on its plan to regain compliance with SEC reporting obligations. The company remains focused on completing its Form 10-Q for the required periods to meet compliance standards. For more information about Celularity, visit their website. For more information, contact Carlos Ramirez, Senior Vice President of Celularity Inc. at [email protected].

Read more at GlobeNewswire: Celularity Receives Nasdaq Notice Regarding Form 10-Q